Loading insider details...
Beta
Latest Form 4 (May 1, 2026): Conversion of 1,419,298 AVLN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 1, 2026 | Avalyn Pharma Inc. (AVLN) | Conversion | 1,419,298 | n/a |
| Apr 28, 2026 | Arcellx, Inc. (ACLX) | Tender of Shares | 1,479,148 | n/a |
| May 30, 2025 | Arcellx, Inc. (ACLX) | Grant/Award | 9,174 | n/a |
| Jun 6, 2024 | Arcellx, Inc. (ACLX) | Grant/Award | 8,011 | n/a |
| Mar 25, 2024 | Arcellx, Inc. (ACLX) | Sale | 504,263 | $35.58M |
| Dec 18, 2023 | Arcellx, Inc. (ACLX) | Sale | 504,263 | $24.77M |
| Jun 16, 2023 | Arcellx, Inc. (ACLX) | Grant/Award | 11,459 | n/a |
| Jun 2, 2023 | Arcellx, Inc. (ACLX) | Sale | 315,164 | $13.08M |
| May 15, 2023 | Arcellx, Inc. (ACLX) | Sale | 631,932 | $28.44M |
| Feb 9, 2022 | Arcellx, Inc. (ACLX) | Conversion | 3,400,144 | n/a |